Since IL-10 plays a crucial role in the pathogenesis of MS and other neurological illnesses (61), any molecule, such as MaR1, that increases the production of IL-10 has significant potential for therapeutic improvement. The gene discussed is IL10; the disease is myeloid sarcoma.